HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,613,000 | 3.70% |
| Monashee Investment Management LLC | 399,910 | $2,899,000 | 0.72% |
| Endowment Wealth Management, Inc. | 96,618 | $700,000 | 0.71% |
| Gladstone Institutional Advisory LLC | 246,717 | $1,789 | 0.14% |
| Diameter Capital Partners LP | 300,338 | $2,177,000 | 0.13% |
| CenterBook Partners LP | 23,706 | $172,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 900,100 | $6,526,000,000 | 0.06% |
| Exos Asset Management LLC | 16,139 | $117,000 | 0.06% |
| Maven Securities LTD | 200,000 | $1,450,000 | 0.04% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 11,000 | $80,000 | 0.04% |